PodcastIntel
Sign in Get Started Free
HCPLive
HCPLive

Efsitora Dosing and Titration in Type 2 Diabetes

Sep 27, 2026 · 0:05:02
Listen to Episode
✨ AI Summary
  • Efsitora alfa-gobe (Onswik) approved for type 2 diabetes.
  • Hosts Diana Isaacs and Natalie Bellini discussed dosing and titration.
  • Approval based on four phase 3 QWINT trials.

More from HCPLive

HCPLive
Subcutaneous Furosemide Bioequivalent to IV, Bioavailable Across Multiple Injection Sites
Oct 12, 2026 · 0:03:18
HCPLive
Targeting Senescent Cells in Actinic Keratosis With RLS-1496
Oct 12, 2026 · 0:04:25
HCPLive
Atopic Dermatitis Biologic Selection, With Raj Chovatiya, MD, PhD
Oct 12, 2026 · 0:03:33
HCPLive
Tovinontrine 50 mg Improves cGMP With Minimal Effect on NT-proBNP in HFpEF
Oct 12, 2026 · 0:06:00
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to HCPLive and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →